These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12395291)

  • 1. [Diagnostic and therapeutic proceedings in pregnancies with blood group incompatibility: A retrospective analysis over 30 years].
    Müller T; Hofmann J; Kristen P; Dietl J
    Z Geburtshilfe Neonatol; 2002; 206(5):182-6. PubMed ID: 12395291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of spectrophotometric examinations of amniotic fluid in pregnancy with incompatibility according to our observation].
    Lozińska D; Grodzicka A
    Pediatr Pol; 1970 Jan; 45(1):63-5. PubMed ID: 5413697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring and treatment of fetal maternal allo-immunization. Role of cordocentesis].
    Donner C; Lambermont M; Karioun A; Paquet V; Vermeylen D; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(8):892-7. PubMed ID: 7706659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrauterine exchange transfusion in cases of iso-immunization].
    Zárate H; Bravo R; Avalos J; Pérez L; Torres B; Rodríguez Argüelles J
    Ginecol Obstet Mex; 1969 Aug; 26(154):221-34. PubMed ID: 4989177
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amniocentesis and associated examinations].
    Abalos Gorostiaga JC
    Arch Fund Roux Ocefa; 1967; 1(1):53-61. PubMed ID: 6070838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intrauterine exchange transfusion in Rh immunization].
    Bollmann R; Schilling H; Ihle W; Möckel A; Zienert A
    Zentralbl Gynakol; 1988; 110(1):54-9. PubMed ID: 3281398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
    Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH
    Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of maternal blood for intrauterine transfusions.
    Eyster ME; Queenan JT; Haber JM
    Obstet Gynecol; 1969 Nov; 34(5):636-40. PubMed ID: 4981597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.